Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong
Contact Us
US: +1 512 898-9222
SG: +65 3138-4148
EMAIL: Inquiry@asiaactual.com
Sign Up For Our Newsletter to Stay Informed
The Health Science Authority to Raise Review Fees in Singapore in July 2022
Published on: January 20th, 2022
These fees are no longer valid, the HSA revised fees again on July 1st, 2024. Find updated HSA fees here.
Singapore’s Health Science Authority (HSA) has announced that they will increase their review fees in Singapore for all registration routes in July 2022. The increased government fees are equivalent to about a 3% increase across the board. For a complete list, please visit the HSA’s official revised schedule of fees. Singapore remains a beacon of regulatory efficiency and market entrance for international medical device manufacturers selling in Asia. With a high standard of living and several leading hospitals in the region, Singapore is an important market for all manufacturer serious about establishing their brand in Asia.
Current fees can be found here and more information on the regulatory process can be found here.
New HSA Government Review Fees in Singapore
The HSA has announced that they will be increasing fees across the board in July 2022. While most fees have increased by about 3%, some of the updated fees can be found below.
Fees | Class B | Class B (New) | Class C | Class C (New) | Class D | Class D (New) | Class D with a registrable drug | Class D with a registrable drug (New) |
Application fee | $515 | $530 | $515 | $530 | $515 | $530 | $515 | $530 |
Immediate route fee | $925 | $950 | $3,090 | $3,180 | N.A. | N.A. | N.A. | N.A. |
Expedited route fee | N.A. | N.A. | $3,090 | $3,180 | $5,560 | $5,730 | N.A. | N.A. |
Abridged route fee | $1,850 | $1,910 | $3,605 | $3,710 | $5,870 | $6,050 | $10,200 | $10,300 |
Full route fee | $3,605 | $3,710 | $5,870 | $6,050 | $11,600 | $11,800 | $75,200 | $75,400 |
All fees are in Singapore dollars. S$1,000 = US$705 as of January 2022
New Change Notification Review Fees in Singapore
The Health Science Authority has also updated the change notification review fees in Singapore by about 3%.
The updated change notification fees are as follows:
Notification Changes | Class B (Old) | Class B (New) | Class C (Old) | Class C (New) | Class D (Old) | Class D (New) |
Administrative | $515 | $530 | $515 | $530 | $515 | $530 |
Review | $515 | $530 | N.A. | N.A. | N.A. | N.A. |
Technical | N.A. | N.A. | $1,750 | $1,800 | $2,880 | $2,970 |
All fees are in Singapore dollars. S$100 = US$70.5 as of January 2022
New Retention Fees in Singapore
Singapore’s Health Science Authority requires license holder pay an annual retention fees to maintain the SMDR listing and has also slightly increased these fees.
Classification | 2021 Fees | New Fees
(beginning July 1, 2022) |
Class B | $36 | $37 |
Class C | $62 | $64 |
Class D | $124 | $128 |
Class D with registrable drug | $124 | $128 |
All fees are in Singapore dollars. S$100 = US$70.5 as of January 2022
Grow with Us
Looking to expand your medical device sales in Asia? Asia Actual is your premier partner, specializing in accelerating market access across the continent. With a team of experienced, bilingual commercial and regulatory experts on the ground, we provide unparalleled support in each market.
As the leading consulting company for medical and diagnostic devices, we offer expedited registration, independent license holding, importing, and comprehensive commercial support services in Singapore.
Contact Asia Actual today if you have questions or need support importing medical products into Singapore.